These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30340917)

  • 21. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of longer-term outcome in the Vienna omega-3 high-risk study.
    Mossaheb N; Schäfer MR; Schlögelhofer M; Klier CM; Smesny S; McGorry PD; Berger M; Amminger GP
    Schizophr Res; 2018 Mar; 193():168-172. PubMed ID: 28823721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial.
    Mallawaarachchi SR; Amminger GP; Farhall J; Bolt LK; Nelson B; Yuen HP; McGorry PD; Markulev C; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2020 Apr; 218():48-54. PubMed ID: 32171637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state.
    de Wit S; Schothorst PF; Oranje B; Ziermans TB; Durston S; Kahn RS
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):865-73. PubMed ID: 24636460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of distress related to attenuated psychotic symptoms in individuals at ultra high risk of psychosis: Findings from the Longitudinal Youth at Risk Study.
    Rekhi G; Rapisarda A; Lee J
    Early Interv Psychiatry; 2019 Feb; 13(1):73-78. PubMed ID: 28560723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Early detection of psychotic disorders].
    Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
    Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
    Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
    J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in triglyceride levels in ultra-high risk for psychosis individuals treated with omega-3 fatty acids.
    Mossaheb N; Papageorgiou K; Schäfer MR; Becker J; Schloegelhofer M; Amminger GP
    Early Interv Psychiatry; 2018 Feb; 12(1):30-36. PubMed ID: 26362578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impairment in Social Functioning differentiates youth meeting Ultra-High Risk for psychosis criteria from other mental health help-seekers: A validation of the Italian version of the Global Functioning: Social and Global Functioning: Role scales.
    Lo Cascio N; Curto M; Pasqualetti P; Lindau JF; Girardi N; Saba R; Brandizzi M; Monducci E; Masillo A; Colafrancesco G; Solfanelli A; De Crescenzo F; Kotzalidis GD; Dario C; Ferrara M; Vicari S; Girardi P; Auther AM; Cornblatt BA; Correll CU; Fiori Nastro P
    Psychiatry Res; 2017 Jul; 253():296-302. PubMed ID: 28412612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
    Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
    Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subjective experience of social cognition in young people at Ultra-High Risk of psychosis: a 2-year longitudinal study.
    Pelizza L; Poletti M; Azzali S; Garlassi S; Scazza I; Paterlini F; Chiri LR; Pupo S; Raballo A
    Nord J Psychiatry; 2021 Feb; 75(2):97-108. PubMed ID: 32762506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychotic conversion of individuals at ultra-high risk for psychosis: The potential roles of schizotypy and basic symptoms.
    Bang M; Park JY; Kim KR; Lee SY; Song YY; Kang JI; Lee E; An SK
    Early Interv Psychiatry; 2019 Jun; 13(3):546-554. PubMed ID: 29218852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
    Pelizza L; Azzali S; Garlassi S; Paterlini F; Scazza I; Chiri LR; Pupo S; Raballo A
    Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis.
    Lavoie S; Jack BN; Griffiths O; Ando A; Amminger P; Couroupis A; Jago A; Markulev C; McGorry PD; Nelson B; Polari A; Yuen HP; Whitford TJ
    Schizophr Res; 2018 Jan; 191():95-100. PubMed ID: 29132815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course.
    Nelson B; Amminger GP; Yuen HP; Markulev C; Lavoie S; Schäfer MR; Hartmann JA; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger G; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; McGorry PD
    NPJ Schizophr; 2018 Jun; 4(1):11. PubMed ID: 29941938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective?
    Mossaheb N; Schäfer MR; Schlögelhofer M; Klier CM; Cotton SM; McGorry PD; Amminger GP
    Schizophr Res; 2013 Aug; 148(1-3):163-7. PubMed ID: 23778032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal patterns of social functioning and conversion to psychosis in subjects at ultra-high risk.
    Jang JH; Shin NY; Shim G; Park HY; Kim E; Jang GE; Kwon SJ; Hur JW; An SK; Kwon JS
    Aust N Z J Psychiatry; 2011 Sep; 45(9):763-70. PubMed ID: 21827349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis.
    Hartmann JA; McGorry PD; Schmidt SJ; Amminger GP; Yuen HP; Markulev C; Berger GE; Chen EYH; de Haan L; Hickie IB; Lavoie S; McHugh MJ; Mossaheb N; Nieman DH; Nordentoft M; Riecher-Rössler A; Schäfer MR; Schlögelhofer M; Smesny S; Thompson A; Verma SK; Yung AR; Nelson B
    Psychother Psychosom; 2017; 86(5):292-299. PubMed ID: 28903120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis.
    Kim SW; Schäfer MR; Klier CM; Berk M; Rice S; Allott K; Bartholomeusz CF; Whittle SL; Pilioussis E; Pantelis C; McGorry PD; Amminger GP
    Schizophr Res; 2014 Sep; 158(1-3):39-44. PubMed ID: 25066495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individual prediction of long-term outcome in adolescents at ultra-high risk for psychosis: Applying machine learning techniques to brain imaging data.
    de Wit S; Ziermans TB; Nieuwenhuis M; Schothorst PF; van Engeland H; Kahn RS; Durston S; Schnack HG
    Hum Brain Mapp; 2017 Feb; 38(2):704-714. PubMed ID: 27699911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.